Therapy-related myeloid neoplasms: pathobiology and clinical characteristics.
Sill
H
H
Department of Internal Medicine, Division of Haematology, Medical University of Graz, Graz, Austria. heinz.sill@medunigraz.at
Olipitz
W
W
Zebisch
A
A
Schulz
E
E
Wölfler
A
A
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects; D020022:Genetic Predisposition to Disease; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced / Q000235:genetics / Q000503:physiopathology / Q000628:therapy; D009190:Myelodysplastic Syndromes / Q000139:chemically induced / Q000235:genetics / Q000503:physiopathology / Q000628:therapy; D016609:Neoplasms, Second Primary / Q000139:chemically induced / Q000235:genetics / Q000503:physiopathology / Q000628:therapy; D011379:Prognosis; D011878:Radiotherapy / Q000009:adverse effects
D000970:Antineoplastic Agents